rfhg_125562.1

Basic information about the TSS

---

TSS ID: rfhg_125562.1 TSS ID(Version3): hg_104993.1 hg_104992.1 Species: human Chr: chr10		Start: 58334961 End: 58335018 Strand: +
Source datasets	FANTOM5|EPD|PRJNA4843412|DRA013844|PRJNA615891|PRJNA401781 |PRJNA548673|PRJNA597322
Protocol	CAGE|TSS_database|NETCAGE|TIF-seq2|STRIPE-seq |ReCappable-seq|SLIC_CAGE
TSS cluster detected*	10

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2347332,EH38E1469588)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000615793.1:0 ENST00000373910.9:0 AK291901:0 BC005980:0 BC015997:0 GeneID: 7321 HGNC/MGI_ID: HGNC:12474 UniProt_ID: A0A024QZJ2 A0A087WW00 Nearer transcript ids and distances: AJ272367:38 AF257220:38 X78140:169 AB590170:182 DQ896385:182 DQ893111:182 KJ892341:183 BT007041:184 view more...

Gene_name: ubiquitin conjugating enzyme E2 D1 Gene_symbol: UBE2D1 Gene_synonyms: E2(17)KB1 UBC4/5 UBCH5 UbcH5A Gene_source: HGNC:12474

TATA-Box annotation

---

Distance to TSS:	10
Nearest PromoterID:	NM_001204880
Entrez ID:	7321
Nearest Unigene:	Hs.129683
Nearest Refseq:	NM_003338
Nearest Ensembl:	ENSG00000072401
Gene Name:	ubiquitin conjugating enzyme E2 D1
Gene Alias:	E2(17)KB1|SFT|UBC4/5|UBCH5|UBCH5A
Gene Type:	protein-coding
CpG%:	0.140351
GC%:	0.620690
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2D1 p2@UBE2D1
Sample		p1@UBE2D1	p2@UBE2D1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	112.99	8.18
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	125.03	5.66
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	109.76	8.10
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	130.15	6.03
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	131.83	5.85
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	133.73	4.85
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	103.93	8.93
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	104.64	7.27
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	92.75	5.34
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	160.56	11.01
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	151.99	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	155.71	7.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	30.30	9.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.35	7.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.32	8.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.65	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.43	7.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.26	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	6.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.52	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.13	8.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.20	4.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.65	6.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.81	5.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.83	9.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	34.82	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	27.11	8.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.74	6.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	23.89	5.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.35	7.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.46	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.93	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.82	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.79	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	32.58	7.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.01	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	39.89	7.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.65	9.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	49.21	9.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	49.64	6.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.70	8.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.07	9.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	49.48	11.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	47.38	11.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	55.14	13.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	61.90	14.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	61.40	10.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	56.97	10.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	47.92	15.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	53.70	10.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	47.81	10.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	47.91	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	34.13	8.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.95	8.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.98	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.63	8.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.26	8.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.43	9.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.97	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.24	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.20	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	22.42	6.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	21.77	9.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	21.30	6.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	5.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.42	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.53	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.80	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.71	6.11
Adipocyte - breast, donor1	11376-118A8	55.91	8.71
Adipocyte - breast, donor2	11327-117E4	45.72	8.50
Adipocyte - omental, donor1	11473-119C6	47.33	8.02
Adipocyte - omental, donor2	11474-119C7	31.39	3.74
Adipocyte - omental, donor3	11475-119C8	34.50	6.03
Adipocyte - perirenal, donor1	11476-119C9	35.09	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	28.45	4.52
Adipocyte - subcutaneous, donor3	11408-118E4	31.28	3.82
Adipocyte differentiation, day04, donor1	13019-139D4	56.91	11.73
Adipocyte differentiation, day04, donor2	13022-139D7	86.48	9.52
Adipocyte differentiation, day04, donor3	13025-139E1	78.89	7.25
Adipocyte differentiation, day04, donor4	13028-139E4	61.72	12.93
Adipocyte differentiation, day08, donor1	13020-139D5	57.91	8.37
Adipocyte differentiation, day08, donor2	13023-139D8	71.65	9.36
Adipocyte differentiation, day08, donor3	13026-139E2	51.19	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	59.54	7.79
Adipocyte differentiation, day12, donor1	13021-139D6	45.33	4.99
Adipocyte differentiation, day12, donor2	13024-139D9	61.28	6.28
Adipocyte differentiation, day12, donor3	13027-139E3	48.76	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	34.71	7.61
Alveolar Epithelial Cells, donor1	11510-119G7	36.02	5.75
Alveolar Epithelial Cells, donor2	11590-120G6	20.08	8.25
Alveolar Epithelial Cells, donor3	11671-122G6	13.18	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	19.07	4.86
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	8.37
Amniotic Epithelial Cells, donor3	11694-123A2	20.34	9.04
Anulus Pulposus Cell, donor1	11248-116E6	31.24	10.18
Anulus Pulposus Cell, donor2	11463-119B5	18.86	6.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	40.44	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	45.15	6.95
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.00	4.18
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	49.32	7.59
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	6.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	49.71	6.82
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	50.00	4.37
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	33.85	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	39.17	5.65
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	40.64	7.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	52.22	8.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	65.51	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.61	4.67
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	39.65	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	40.81	6.99
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	47.04	5.08
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	39.99	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.15	5.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	36.02	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	41.85	6.52
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	54.53	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	46.12	5.34
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	41.36	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	46.74	5.70
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	41.47	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.71	5.42
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.64	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	45.98	4.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	41.38	4.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	43.87	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	41.25	5.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	37.12	6.61
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	40.75	4.33
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	33.67	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	39.27	6.90
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.18	6.14
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	35.96	4.35
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	46.29	6.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	36.79	6.10
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	52.32	5.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	42.72	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	52.49	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	42.07	5.52
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.37	5.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	51.61	6.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	34.27	4.59
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	55.93	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.23	5.54
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	38.14	9.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	42.65	5.54
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.10	3.97
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.53	5.45
Astrocyte - cerebellum, donor1	11500-119F6	33.53	9.46
Astrocyte - cerebellum, donor2	11580-120F5	16.94	6.33
Astrocyte - cerebellum, donor3	11661-122F5	21.60	5.03
Astrocyte - cerebral cortex, donor1	11235-116D2	37.30	12.20
Astrocyte - cerebral cortex, donor2	11316-117D2	41.41	13.43
Astrocyte - cerebral cortex, donor3	11392-118C6	44.30	10.14
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	52.87	19.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	62.52	17.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.22	18.55
Basophils, donor1	12241-129G9	176.53	6.80
Basophils, donor2	12242-129H1	202.77	13.35
Basophils, donor3	12243-129H2	201.83	9.11
Bronchial Epithelial Cell, donor1	11511-119G8	18.54	4.31
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	8.32	2.70
Bronchial Epithelial Cell, donor6	11461-119B3	4.61	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	24.47	4.68
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	38.43	10.25
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	33.26	6.72
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34
CD14+ Monocytes, donor1	11224-116B9	419.85	13.53
CD14+ Monocytes, donor2	11305-117B9	565.15	21.34
CD14+ Monocytes, donor3	11381-118B4	531.72	15.37
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	159.07	7.64
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	144.05	4.93
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	179.82	8.55
CD14+ monocytes - mock treated, donor1	11863-125A9	163.63	7.66
CD14+ monocytes - mock treated, donor2	11873-125C1	224.20	5.13
CD14+ monocytes - mock treated, donor3	11883-125D2	215.81	5.45
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	206.74	6.19
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	239.30	7.18
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	288.34	8.93
CD14+ monocytes - treated with BCG, donor1	11860-125A6	417.64	10.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	426.60	13.35
CD14+ monocytes - treated with BCG, donor3	11880-125C8	500.33	11.10
CD14+ monocytes - treated with Candida, donor1	11868-125B5	876.80	16.62
CD14+ monocytes - treated with Candida, donor2	11878-125C6	768.81	21.12
CD14+ monocytes - treated with Candida, donor3	11888-125D7	798.74	14.42
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	160.35	7.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	171.81	3.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	195.92	7.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	636.25	10.98
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	646.49	7.01
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	678.70	5.67
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	427.16	18.83
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	475.40	14.31
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	479.74	17.67
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	593.39	11.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	692.91	15.85
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	709.42	10.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	336.54	12.55
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	477.60	14.50
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	494.25	16.38
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	593.35	10.24
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	700.03	13.21
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	713.14	10.67
CD14+CD16+ Monocytes, donor1	11789-124B7	180.69	9.37
CD14+CD16+ Monocytes, donor2	11801-124D1	188.03	10.39
CD14+CD16+ Monocytes, donor3	11912-125G4	203.19	12.13
CD14+CD16- Monocytes, donor1	11788-124B6	292.91	16.20
CD14+CD16- Monocytes, donor2	11799-124C8	335.14	16.42
CD14+CD16- Monocytes, donor3	11910-125G2	364.33	12.49
CD14-CD16+ Monocytes, donor1	11790-124B8	130.90	11.74
CD14-CD16+ Monocytes, donor2	11800-124C9	141.18	11.86
CD14-CD16+ Monocytes, donor3	11911-125G3	140.43	10.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	14.23
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	71.19	10.17
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	61.10	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	98.08	18.12
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	72.37	16.62
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.79	18.25
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	78.44	19.61
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	72.51	15.82
CD19+ B Cells, donor1	11544-120B5	69.86	8.22
CD19+ B Cells, donor2	11624-122B4	71.09	5.80
CD19+ B Cells, donor3	11705-123B4	78.75	8.08
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.46	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.59	1.60
CD34+ Progenitors, donor1	11545-120B6	22.09	5.02
CD34+ Progenitors, donor2	11625-122B5	173.04	8.99
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.81	7.52
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.56	8.79
CD4+ T Cells, donor1	11225-116C1	67.13	6.07
CD4+ T Cells, donor2	11306-117C1	50.83	6.12
CD4+ T Cells, donor3	11382-118B5	49.71	7.32
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.09	7.15
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.17	9.21
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.88	11.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	49.31	8.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	55.48	10.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.37	9.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	33.55	9.49
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.60	8.87
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	36.76	9.41
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	49.96	10.83
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	53.24	9.68
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	41.32	9.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	34.49	8.31
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.43	8.69
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	65.26	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	58.95	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	45.99	9.83
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	42.24	6.07
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	36.15	5.67
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	45.50	10.11
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	51.56	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.50	6.54
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	59.38	16.83
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	96.65	14.40
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	80.49	11.78
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	89.32	21.56
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	80.22	14.32
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	73.40	8.31
CD8+ T Cells, donor1	11226-116C2	55.66	8.84
CD8+ T Cells, donor2	11307-117C2	54.44	6.76
CD8+ T Cells, donor3	11383-118B6	60.09	7.83
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	32.34	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.99	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	32.28	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	35.04	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	35.47	3.64
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.77	3.69
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.01	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.89	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	33.81	5.13
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.18	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.71	4.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.20	4.38
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	33.13	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.47	3.74
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	26.16	4.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	33.27	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	28.91	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.81	3.21
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.13	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	36.65	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	43.87	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	43.36	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	35.67	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	35.06	1.00
Cardiac Myocyte, donor1	11525-119I4	148.05	38.38
Cardiac Myocyte, donor2	11605-120I3	34.09	6.42
Cardiac Myocyte, donor3	11686-122I3	27.47	6.21
Chondrocyte - de diff, donor1	11261-116G1	27.73	3.47
Chondrocyte - de diff, donor2	11338-117F6	26.30	3.20
Chondrocyte - de diff, donor3	11410-118E6	40.39	6.03
Chondrocyte - re diff, donor2	11339-117F7	36.71	4.48
Chondrocyte - re diff, donor3	11411-118E7	22.65	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	45.79	14.80
Ciliary Epithelial Cells, donor2	11323-117D9	38.69	6.84
Ciliary Epithelial Cells, donor3	11399-118D4	36.90	12.74
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.59	6.51
Corneal Epithelial Cells, donor1	11526-119I5	15.81	3.73
Corneal Epithelial Cells, donor2	11606-120I4	6.83	3.41
Corneal Epithelial Cells, donor3	11687-122I4	15.08	4.60
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	41.44	3.47
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	37.22	2.84
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.49	5.29
Dendritic Cells - plasmacytoid, donor1	11228-116C4	42.36	5.81
Dendritic Cells - plasmacytoid, donor2	11309-117C4	39.17	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.91	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	15.18	4.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	22.34	5.09
Endothelial Cells - Aortic, donor3	11412-118E8	19.66	4.72
Endothelial Cells - Artery, donor1	11264-116G4	22.40	2.91
Endothelial Cells - Artery, donor2	11341-117F9	36.70	8.71
Endothelial Cells - Artery, donor3	11413-118E9	18.41	4.03
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.60	8.64
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.34	9.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.65	8.74
Endothelial Cells - Microvascular, donor1	11265-116G5	16.05	6.24
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	4.17
Endothelial Cells - Microvascular, donor3	11414-118F1	14.89	6.81
Endothelial Cells - Thoracic, donor1	11266-116G6	39.21	10.80
Endothelial Cells - Thoracic, donor2	11343-117G2	23.59	7.86
Endothelial Cells - Umbilical vein, donor1	11243-116E1	46.72	18.89
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.46	13.90
Endothelial Cells - Umbilical vein, donor3	11400-118D5	48.85	19.17
Endothelial Cells - Vein, donor1	11267-116G7	23.89	6.83
Endothelial Cells - Vein, donor2	11344-117G3	10.48	4.19
Endothelial Cells - Vein, donor3	11416-118F3	34.23	11.78
Eosinophils, donor1	12244-129H3	91.48	0.00
Eosinophils, donor2	12245-129H4	463.72	21.45
Eosinophils, donor3	12246-129H5	945.21	35.67
Esophageal Epithelial Cells, donor1	11507-119G4	17.59	3.66
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.91	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.38	2.85
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	33.69	6.61
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.26	6.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.80	3.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.49	6.33
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.04	2.63
Fibroblast - Aortic Adventitial, donor3	11401-118D6	38.87	6.98
Fibroblast - Cardiac, donor1	11268-116G8	24.95	3.18
Fibroblast - Cardiac, donor2	11345-117G4	15.16	2.27
Fibroblast - Cardiac, donor3	11417-118F4	19.40	3.94
Fibroblast - Cardiac, donor4	11452-119A3	39.40	9.09
Fibroblast - Cardiac, donor5	11456-119A7	27.41	8.76
Fibroblast - Cardiac, donor6	11460-119B2	31.83	8.19
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.73	7.91
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.55	6.04
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	29.75	5.77
Fibroblast - Conjunctival, donor3	11692-122I9	34.94	13.57
Fibroblast - Dermal, donor1	11269-116G9	29.58	6.57
Fibroblast - Dermal, donor2	11346-117G5	14.15	3.30
Fibroblast - Dermal, donor3	11418-118F5	36.99	7.49
Fibroblast - Dermal, donor4	11450-119A1	28.71	10.97
Fibroblast - Dermal, donor5	11454-119A5	36.29	13.08
Fibroblast - Dermal, donor6	11458-119A9	35.57	12.99
Fibroblast - Gingival, donor1	11237-116D4	27.69	9.16
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.94	5.24
Fibroblast - Gingival, donor2	11318-117D4	34.66	9.62
Fibroblast - Gingival, donor3	11394-118C8	33.26	10.44
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	8.31
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	34.54	5.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.32	5.77
Fibroblast - Gingival, donor6 (control)	11922-125H5	28.53	4.73
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	6.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	39.49	6.43
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	33.13	5.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	33.68	6.80
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.28	11.89
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	10.45
Fibroblast - Lung, donor3	11419-118F6	25.32	10.13
Fibroblast - Lymphatic, donor1	11506-119G3	39.99	6.66
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	8.39
Fibroblast - Lymphatic, donor3	11667-122G2	11.75	3.36
Fibroblast - Mammary, donor1	11540-120B1	36.94	8.53
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.07	8.92
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.78	19.57
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.13	10.71
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.91	7.63
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.44	5.13
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	41.63	6.15
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.71	7.74
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	46.94	10.16
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.14	6.33
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.83	3.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.40	5.15
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.94	5.12
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.36	3.61
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	43.29	6.15
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.57	5.57
Fibroblast - skin normal, donor1	11553-120C5	31.01	6.40
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.65	5.01
Fibroblast - skin normal, donor2	11561-120D4	32.55	6.63
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	26.90	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.96	7.54
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	51.46	7.86
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.23	2.63
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	28.44	5.33
Fibroblast - skin walker warburg, donor1	11554-120C6	22.60	4.39
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.66	3.92
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	47.93	6.10
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	57.55	5.72
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	39.30	8.59
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.39	9.71
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	16.84
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	59.34	16.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	45.64	28.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	47.98	23.72
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.01	14.61
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.56	38.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.88	25.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.53	19.24
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.92	42.45
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.29	30.81
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	49.26	21.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.32	22.56
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	68.64	25.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.12	35.58
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	58.35	19.92
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.33	17.57
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	61.04	23.17
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	55.08	25.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	66.48	15.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	62.15	17.49
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	58.98	23.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	67.75	19.76
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	70.40	17.98
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	72.36	24.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.46	20.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	74.29	13.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	53.67	15.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.66	15.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.73	14.91
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.67	14.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	58.34	15.22
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.03	12.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.53	9.26
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.47	14.39
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.68	11.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	68.31	14.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	53.35	11.94
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.61	9.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	57.17	10.64
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.20	11.92
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.28	7.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	59.76	12.91
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	44.53	12.87
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.59	7.75
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.41	9.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	44.43	9.97
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.91	9.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	63.42	11.06
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.04	9.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	60.50	14.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	55.40	12.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.21	11.50
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	66.34	19.06
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.00	36.43
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	47.76	32.82
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	49.51	54.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	40.68	19.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	43.80	18.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.51	23.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	58.79	23.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	57.76	24.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	19.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	57.94	21.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.12	19.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	29.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.78	15.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	57.85	20.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	19.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	58.21	24.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	20.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	59.56	18.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.67	12.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	47.44	18.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	74.14	23.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	53.85	15.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.51	13.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.07	14.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	50.16	22.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	55.86	18.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	79.08	12.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	40.58	8.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	50.69	11.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	58.50	14.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.85	11.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.84	11.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	55.48	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.84	11.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.03	8.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	42.38	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	39.79	7.76
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.86	4.99
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	5.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	44.72	7.29
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.91	5.43
Hep-2 cells mock treated, biol_rep1	11898-125E8	24.25	5.34
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.19	4.05
Hep-2 cells mock treated, biol_rep3	11900-125F1	28.67	2.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.39	3.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	30.09	3.65
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.33	3.88
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	24.91	4.48
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.82	2.40
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	30.11	3.84
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.15	6.72
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	25.53	5.19
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.28	8.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	22.52	6.54
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.30	3.85
Hepatocyte, donor1	11523-119I2	18.16	4.84
Hepatocyte, donor2	11603-120I1	51.71	2.15
Hepatocyte, donor3	11684-122I1	30.68	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.91	8.48
Intestinal epithelial cells (polarized), donor1	11246-116E4	140.70	21.67
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.83	7.13
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	4.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.29	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.56	4.63
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	5.52
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	2.11
Keratinocyte - epidermal, donor1	11272-116H3	27.01	6.77
Keratinocyte - epidermal, donor2	11349-117G8	2.93	1.76
Keratinocyte - epidermal, donor3	11421-118F8	30.86	7.95
Keratinocyte - oral, donor1	11251-116E9	42.46	16.46
Keratocytes, donor1	11527-119I6	24.07	6.53
Keratocytes, donor2	11607-120I5	15.23	4.69
Keratocytes, donor3	11688-122I5	38.53	9.48
Krukenberg tumor cell line:HSKTC	10687-109F3	457.17	6.59
Lens Epithelial Cells, donor1	11529-119I8	30.20	3.24
Lens Epithelial Cells, donor2	11609-120I7	39.44	12.69
Lens Epithelial Cells, donor3	11690-122I7	33.20	9.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.11	5.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.12	5.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.79	8.50
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	21.51	4.84
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.03	4.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.76	3.13
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.75	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.60	3.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.02	3.66
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	4.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.51	5.62
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	2.41
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.56	6.27
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.83	5.25
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.42	3.43
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.48	7.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.17	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.76	4.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.47	3.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	3.88
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.62	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.93	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	7.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.31	6.49
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.67	3.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.86	5.83
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.67	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	6.78
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.52	7.28
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.67	2.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.77	5.18
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.31	4.94
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.01	2.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	7.40
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	26.48	6.09
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.98	4.90
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.18	4.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.57	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.76	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.20	7.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.29	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	2.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	6.19
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	2.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.14	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	18.41	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	5.94
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	5.08
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.34	6.70
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.54	4.75
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.78	3.78
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.66	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.63	3.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	5.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.41	5.29
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	26.65	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.92	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.14	6.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.27	4.35
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.00	6.14
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.83	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.82	6.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.54	5.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.06	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.11	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.66	5.53
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.15	9.19
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	20.65	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.57	4.22
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.29	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	20.33	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.09	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	22.40	6.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.32	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.15	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	15.64	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.25	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.03	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.78	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	8.14
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.01	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	18.40	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.12	6.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.53	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.05	5.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.38	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.85	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.20	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.38	5.25
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.69	6.15
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.41	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	5.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.29	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.67	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	6.36
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	28.56	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	5.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	5.32
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.11	8.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.35	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	6.40
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.65	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.93	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.13	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.39	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.54	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	19.40	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.20	5.88
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	19.80	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	19.38	6.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	15.34	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.00	5.46
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	22.55	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	8.31
Macrophage - monocyte derived, donor1	11232-116C8	140.17	7.75
Macrophage - monocyte derived, donor2	11313-117C8	112.12	2.57
Macrophage - monocyte derived, donor3	11389-118C3	158.87	8.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	46.73	6.90
Mallassez-derived cells, donor2	11929-125I3	55.78	6.81
Mallassez-derived cells, donor3	11930-125I4	51.15	7.78
Mammary Epithelial Cell, donor1	11273-116H4	31.99	6.78
Mammary Epithelial Cell, donor2	11350-117G9	33.30	4.34
Mammary Epithelial Cell, donor3	11422-118F9	9.23	1.25
Mast cell - stimulated, donor1	11487-119E2	141.01	16.27
Mast cell, donor1	11563-120D6	31.90	6.70
Mast cell, donor2	11565-120D8	32.99	5.65
Mast cell, donor3	11566-120D9	29.72	6.08
Mast cell, donor4	11567-120E1	37.23	6.56
Mast cell, expanded and stimulated, donor5	11940-126A5	36.37	9.98
Mast cell, expanded and stimulated, donor8	11942-126A7	35.60	7.59
Mast cell, expanded, donor5	11939-126A4	33.50	10.44
Mast cell, expanded, donor8	11941-126A6	38.16	13.72
Melanocyte - dark, donor1	11502-119F8	22.19	12.24
Melanocyte - dark, donor2	11582-120F7	29.76	6.58
Melanocyte - dark, donor3	11663-122F7	38.32	7.68
Melanocyte - light, donor1	11274-116H5	9.40	1.88
Melanocyte - light, donor2	11351-117H1	4.78	1.36
Melanocyte - light, donor3	11423-118G1	6.07	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	29.68	8.12
Melanocyte, donor2 (MC+2)	12739-135I3	17.48	3.23
Melanocyte, donor3 (MC+3)	12837-137B2	44.73	8.04
Meningeal Cells, donor1	11493-119E8	30.64	12.28
Meningeal Cells, donor2	11573-120E7	37.41	8.80
Meningeal Cells, donor3	11654-122E7	35.05	12.31
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.23	8.55
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.17	5.64
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	8.61
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.35	5.29
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.22	6.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	24.17	6.15
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	22.65	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.05	7.77
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.98	7.76
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.53	4.83
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.45	8.29
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.10	2.37
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	10.25
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.52	9.92
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.71	7.51
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.03	7.26
Mesothelial Cells, donor1	11247-116E5	44.81	8.75
Mesothelial Cells, donor2	12156-128G5	47.54	6.51
Mesothelial Cells, donor3	11402-118D7	37.87	8.89
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	85.07	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	160.08	4.93
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	111.89	4.12
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	134.83	5.89
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	95.83	4.77
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	191.70	5.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	123.35	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	179.64	4.67
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	100.97	5.94
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	146.90	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	132.22	3.80
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	5.26
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	210.31	6.37
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	127.99	5.52
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	219.37	5.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	40.24	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	269.47	5.27
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	160.90	3.33
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	69.11	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	311.98	7.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	190.36	5.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	216.47	7.75
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	270.10	4.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	200.95	8.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	82.55	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	287.57	5.48
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	199.74	9.63
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	76.22	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	313.10	6.25
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	217.92	10.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	86.14	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	197.51	4.32
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	202.92	8.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	123.41	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	186.21	7.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	114.16	18.35
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	203.20	11.39
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	99.33	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	104.38	12.81
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	245.69	8.93
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	105.08	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	95.02	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	305.64	9.57
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	114.22	9.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	149.85	10.65
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	332.73	11.22
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	118.04	4.57
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	136.95	12.24
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	296.24	12.97
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	172.80	5.43
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	180.47	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	312.16	7.39
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	195.78	9.68
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	236.15	14.65
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	340.52	9.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	226.50	14.59
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	146.73	14.61
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	330.14	11.21
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	289.75	9.88
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	257.79	12.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	383.49	12.42
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	207.86	9.29
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	198.70	11.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	411.10	13.92
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	244.82	10.32
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	200.06	14.34
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	373.12	10.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	305.05	8.36
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	286.44	9.07
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	387.71	10.12
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	120.54	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	149.71	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	162.64	5.59
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	119.92	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	98.05	4.74
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	85.68	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	83.74	8.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	77.77	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	156.76	6.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	114.19	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	140.71	5.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	132.23	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	202.02	4.81
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	88.87	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	96.95	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	125.65	5.90
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	196.12	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	153.86	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	195.98	6.48
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	117.81	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	354.03	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	241.42	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	190.10	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	276.08	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.16	3.66
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	34.49	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	15.35
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.20	9.18
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	38.98	19.01
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	27.13
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	6.80
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.20	11.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.31	6.97
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	37.02	16.75
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.74	11.77
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	29.29	9.43
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	32.75	7.31
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.94	7.03
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	51.60	14.37
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	46.48	7.84
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	38.72	11.14
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	37.82	7.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	49.23	9.52
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	29.76	9.43
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	54.15	11.11
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	39.38	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.78	5.06
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	31.81	5.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	30.01	12.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	60.68	22.76
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.22	13.59
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.06	7.20
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	34.89	9.97
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.77	7.30
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	45.98	9.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	48.24	5.86
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	31.35	6.75
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	6.50
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.51	7.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	33.89	5.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	37.91	13.07
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	49.75	12.21
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.10	11.46
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	36.57	5.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	36.71	8.43
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.50	9.19
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.60	6.96
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	42.22	7.51
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	29.14	16.94
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	8.54
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.98	7.55
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	44.19	14.83
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	6.33
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	65.75	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	5.06
Myoblast, donor1	11241-116D8	28.70	5.09
Myoblast, donor2	11322-117D8	41.23	9.59
Myoblast, donor3	11398-118D3	29.93	7.40
NK T cell leukemia cell line:KHYG-1	10777-110G3	71.36	9.63
Natural Killer Cells, donor1	11230-116C6	59.66	7.07
Natural Killer Cells, donor2	11311-117C6	35.58	7.54
Natural Killer Cells, donor3	11387-118C1	62.95	6.26
Neural stem cells, donor1	11275-116H6	57.34	14.52
Neural stem cells, donor2	11352-117H2	123.24	26.96
Neurons, donor1	11494-119E9	152.48	7.97
Neurons, donor2	11574-120E8	90.49	16.07
Neurons, donor3	11655-122E8	76.46	13.15
Neutrophils, donor1	11233-116C9	685.80	22.27
Neutrophils, donor2	11314-117C9	527.60	17.39
Neutrophils, donor3	11390-118C4	1855.74	83.07
Nucleus Pulposus Cell, donor1	11252-116F1	47.14	11.40
Nucleus Pulposus Cell, donor2	11409-118E5	39.07	11.40
Nucleus Pulposus Cell, donor3	11462-119B4	26.67	4.41
Olfactory epithelial cells, donor1	11933-125I7	15.83	6.33
Olfactory epithelial cells, donor2	11934-125I8	18.24	6.51
Olfactory epithelial cells, donor3	11935-125I9	22.81	5.11
Olfactory epithelial cells, donor4	11936-126A1	25.62	7.40
Oligodendrocyte - precursors, donor1	11496-119F2	39.72	13.84
Osteoblast - differentiated, donor1	11276-116H7	13.19	1.49
Osteoblast - differentiated, donor2	11353-117H3	21.72	4.57
Osteoblast - differentiated, donor3	11425-118G3	22.97	6.83
Osteoblast, donor1	11277-116H8	8.60	2.54
Osteoblast, donor2	11354-117H4	33.01	7.02
Osteoblast, donor3	11426-118G4	20.08	6.04
Pancreatic stromal cells, donor1	11249-116E7	26.28	6.57
Pericytes, donor1	11491-119E6	15.69	4.90
Pericytes, donor2	11571-120E5	23.54	6.56
Pericytes, donor3	11652-122E5	21.16	6.51
Perineurial Cells, donor1	11499-119F5	25.77	7.57
Perineurial Cells, donor2	11579-120F4	34.32	9.02
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	191.88	14.02
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	189.52	10.53
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	160.09	11.13
Placental Epithelial Cells, donor1	11278-116H9	27.26	1.91
Placental Epithelial Cells, donor2	11355-117H5	17.74	3.33
Placental Epithelial Cells, donor3	11427-118G5	11.19	2.75
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	34.81	3.48
Preadipocyte - breast, donor1	11467-119B9	47.46	8.07
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.45	4.05
Preadipocyte - breast, donor2	11328-117E5	45.71	6.53
Preadipocyte - omental, donor1	11468-119C1	44.01	6.29
Preadipocyte - omental, donor2	11329-117E6	46.27	9.60
Preadipocyte - omental, donor3	11403-118D8	35.24	6.30
Preadipocyte - perirenal, donor1	11469-119C2	20.67	5.91
Preadipocyte - subcutaneous, donor1	11279-116I1	10.75	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	48.70	8.15
Preadipocyte - subcutaneous, donor3	11428-118G6	46.32	8.68
Preadipocyte - visceral, donor1	11280-116I2	41.73	8.66
Preadipocyte - visceral, donor2	11357-117H7	42.34	11.04
Preadipocyte - visceral, donor3	11429-118G7	28.42	6.37
Prostate Epithelial Cells (polarized), donor1	11253-116F2	134.26	23.23
Prostate Epithelial Cells, donor2	11331-117E8	44.42	6.64
Prostate Epithelial Cells, donor3	11404-118D9	29.95	5.39
Prostate Stromal Cells, donor1	11254-116F3	26.42	5.70
Prostate Stromal Cells, donor2	11332-117E9	30.30	8.79
Prostate Stromal Cells, donor3	11405-118E1	40.46	7.92
Renal Cortical Epithelial Cells, donor1	11516-119H4	21.53	7.66
Renal Cortical Epithelial Cells, donor2	11596-120H3	45.88	15.32
Renal Epithelial Cells, donor1	11517-119H5	18.26	8.62
Renal Epithelial Cells, donor2	11597-120H4	23.47	9.25
Renal Epithelial Cells, donor3	11678-122H4	53.89	15.67
Renal Glomerular Endothelial Cells, donor1	11514-119H2	20.43	7.49
Renal Glomerular Endothelial Cells, donor2	11594-120H1	31.00	7.82
Renal Glomerular Endothelial Cells, donor3	11675-122H1	44.40	8.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	5.32
Renal Mesangial Cells, donor1	11518-119H6	24.21	7.92
Renal Mesangial Cells, donor2	11598-120H5	25.71	11.91
Renal Mesangial Cells, donor3	11679-122H5	15.54	4.44
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.95	10.47
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.04	4.64
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.89	10.99
Retinal Pigment Epithelial Cells, donor0	11215-116A9	27.48	11.67
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.48	6.82
Retinal Pigment Epithelial Cells, donor2	11608-120I6	20.58	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	36.38	10.04
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	58.53	7.08
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	6.25
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.91	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.22	8.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.37	7.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.19	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	36.70	7.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	31.01	6.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	36.36	7.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	33.98	7.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.97	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.93	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.15	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	34.14	4.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.34	6.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.65	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	41.10	6.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.72	7.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	44.91	8.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.69	7.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.01	8.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	33.80	6.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	38.02	6.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.03	5.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	31.10	5.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	40.11	6.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	29.55	5.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	32.77	6.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	50.71	7.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	29.17	8.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.38	6.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	44.17	5.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.10	7.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.63	7.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.85	7.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.44	8.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.79	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	43.84	6.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	31.82	9.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.46	8.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.88	6.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.71	6.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.32	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	41.34	6.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.48	5.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	48.97	9.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.41	3.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.05	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.92	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.33	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	54.44	8.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	30.42	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	31.35	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.17	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	41.04	7.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.60	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.70	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.86	6.61
Schwann Cells, donor1	11498-119F4	19.94	7.90
Schwann Cells, donor2	11578-120F3	30.62	0.00
Schwann Cells, donor3	11659-122F3	38.78	8.54
Sebocyte, donor1	11220-116B5	24.10	9.31
Sebocyte, donor2	11301-117B5	22.06	5.06
Sebocyte, donor3	11378-118B1	22.26	7.83
Sertoli Cells, donor1	11255-116F4	53.01	4.97
Sertoli Cells, donor2	11333-117F1	31.07	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.30	8.36
Skeletal Muscle Cells, donor2	11358-117H8	8.67	2.17
Skeletal Muscle Cells, donor3	11430-118G8	13.38	2.51
Skeletal Muscle Cells, donor4	11451-119A2	29.53	7.23
Skeletal Muscle Cells, donor5	11455-119A6	30.77	11.59
Skeletal Muscle Cells, donor6	11459-119B1	38.63	11.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.72	12.73
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.81	11.42
Skeletal Muscle Satellite Cells, donor3	11397-118D2	48.71	13.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	38.00	7.75
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.28	4.27
Skin - palm, donor1	10286-104F7	24.17	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	37.05	8.79
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	93.24	14.72
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	37.91	8.70
Small Airway Epithelial Cells, donor1	11256-116F5	35.59	6.67
Small Airway Epithelial Cells, donor2	11334-117F2	38.12	8.86
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	44.19	8.88
Small Airway Epithelial Cells, donor3	11406-118E2	36.58	10.19
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.85	6.17
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.35	3.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.10	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.25	5.52
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	21.63	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	46.03	9.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	12.78	2.66
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.60	5.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.15	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.07	5.21
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.30	6.79
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.89	8.54
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.82	7.32
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	49.32	13.40
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.07	2.53
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.11	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.17	8.26
Smooth Muscle Cells - Colonic, donor2	11320-117D6	40.90	8.61
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.22	9.03
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.06	2.32
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.62	3.89
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.36	5.12
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	49.79	14.21
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.87	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	52.79	8.65
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.92	7.95
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.83	5.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.69	6.89
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.83	6.09
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.67	3.92
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	5.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	19.38
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.28	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.43	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	3.83
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	37.32	12.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	37.84	11.68
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.20	2.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.38	2.55
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.34	2.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.77	9.08
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.31	7.96
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.86	3.33
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.30	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.84	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.41	4.39
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	48.01	8.94
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.45	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.88	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	48.15	6.47
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.93	4.26
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	29.54	7.09
Smooth muscle cells - airway, control, donor1	11966-126D4	36.06	7.11
Smooth muscle cells - airway, control, donor2	11967-126D5	32.74	5.19
Smooth muscle cells - airway, control, donor3	11968-126D6	34.28	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	42.63	5.96
Synoviocyte, donor1	11291-117A4	41.58	6.56
Synoviocyte, donor2	11368-117I9	48.28	5.87
Synoviocyte, donor3	11440-118H9	47.36	5.59
Trabecular Meshwork Cells, donor1	11532-120A2	26.09	6.43
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	12.27	7.64
Tracheal Epithelial Cells, donor1	11292-117A5	16.20	5.59
Tracheal Epithelial Cells, donor2	11369-118A1	10.44	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	54.87	5.66
Urethra, donor2	10319-105A4	68.34	14.39
Urothelial Cells, donor1	11520-119H8	24.18	8.77
Urothelial Cells, donor2	11600-120H7	22.43	6.41
Urothelial Cells, donor3	11681-122H7	16.96	4.81
Urothelial cells, donor0	11216-116B1	41.46	12.48
Whole blood (ribopure), donor090309, donation1	12179-129A1	276.72	12.46
Whole blood (ribopure), donor090309, donation2	12180-129A2	271.63	18.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	233.42	13.01
Whole blood (ribopure), donor090325, donation1	12176-128I7	228.98	12.74
Whole blood (ribopure), donor090325, donation2	12177-128I8	282.96	13.36
Whole blood (ribopure), donor090612, donation1	12182-129A4	282.18	21.87
Whole blood (ribopure), donor090612, donation2	12183-129A5	271.67	14.68
Whole blood (ribopure), donor090612, donation3	12184-129A6	202.66	10.95
Wilms' tumor cell line:G-401	10809-111A8	31.09	12.83
Wilms' tumor cell line:HFWT	10597-108E3	29.92	14.96
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	87.43	16.48
achilles tendon, donor2	10292-104G4	97.13	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.91	8.16
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.17	15.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	50.93	11.87
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	45.99	10.34
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.46	9.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	48.01	9.09
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.44	11.43
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	38.34	7.93
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.78	14.70
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	42.71	9.71
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.86	7.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	44.85	7.90
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	66.54	15.53
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.11	14.61
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	56.70	11.62
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	83.90	13.57
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.66	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	14.08	11.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	15.47	9.10
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.96	7.94
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.08	10.47
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.36	7.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	22.30
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.74	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.04	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	16.87
adenocarcinoma cell line:IM95m	10796-110I4	44.98	13.89
adipose tissue, adult, pool1	10010-101C1	49.95	6.20
adipose, donor1	10184-103D4	42.22	15.83
adipose, donor2	10185-103D5	36.50	10.95
adipose, donor3	10186-103D6	33.76	14.43
adipose, donor4	10187-103D7	45.94	26.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.04	24.62
adrenal gland, adult, pool1	10081-102A9	18.19	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	43.09	7.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	76.46	18.94
amniotic membrane cells, donor1	12235-129G3	48.69	3.48
amniotic membrane cells, donor2	12236-129G4	31.78	5.07
amniotic membrane cells, donor3	12237-129G5	45.37	2.65
amygdala - adult, donor10196	10167-103B5	71.15	7.11
amygdala, adult, donor10252	10151-102I7	80.30	7.30
amygdala, newborn, donor10223	10360-105E9	61.00	4.84
anaplastic carcinoma cell line:8305C	10428-106D5	49.28	3.95
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	53.83	12.80
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	100.21	14.70
aorta, adult, pool1	10052-101G7	34.72	7.45
appendix, adult	10189-103D9	57.05	9.31
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.76	11.35
artery, adult	10190-103E1	355.98	5.43
astrocytoma cell line:TM-31	10425-106D2	304.95	40.85
b cell line:RPMI1788	10427-106D4	20.07	6.99
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.13	6.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	63.81	11.31
bile duct carcinoma cell line:TFK-1	10496-107C1	26.61	4.52
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	18.45	8.95
bladder, adult, pool1	10011-101C2	44.11	9.56
blood, adult, pool1	10053-101G8	110.73	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	4.28
bone marrow, adult	10192-103E3	56.01	7.42
brain, adult, donor1	10084-102B3	34.85	3.08
brain, adult, pool1	10012-101C3	48.33	7.35
brain, fetal, pool1	10085-102B4	53.43	8.01
breast carcinoma cell line:MCF7	10482-107A5	64.42	31.05
breast carcinoma cell line:MDA-MB-453	10419-106C5	32.45	9.49
breast, adult, donor1	10080-102A8	34.72	12.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.76	11.69
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.21	17.01
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.13	6.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.95	6.54
carcinoid cell line:NCI-H1770	10703-109H1	23.51	9.40
carcinoid cell line:NCI-H727	10735-110B6	37.52	9.95
carcinoid cell line:SK-PN-DW	10719-109I8	22.82	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	57.49	18.90
caudate nucleus - adult, donor10196	10177-103C6	70.23	5.76
caudate nucleus, adult, donor10252	10164-103B2	66.60	7.03
caudate nucleus, adult, donor10258	10379-105H1	64.19	5.35
caudate nucleus, newborn, donor10223	10354-105E3	80.21	5.13
cerebellum - adult, donor10196	10173-103C2	78.66	11.65
cerebellum, adult, donor10252	10166-103B4	102.49	10.25
cerebellum, adult, pool1	10083-102B2	39.32	2.76
cerebellum, newborn, donor10223	10357-105E6	117.90	19.93
cerebral meninges, adult	10188-103D8	56.73	7.31
cerebrospinal fluid, donor2	10294-104G6	390.29	8.04
cervical cancer cell line:D98-AH2	10552-107I3	30.19	5.90
cervical cancer cell line:ME-180	10553-107I4	42.75	4.64
cervix, adult, pool1	10013-101C4	42.52	10.08
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.34	8.36
chondrosarcoma cell line:SW 1353	10700-109G7	47.03	23.51
choriocarcinoma cell line:BeWo	10423-106C9	27.96	12.68
choriocarcinoma cell line:SCH	10785-110H2	24.64	8.62
choriocarcinoma cell line:T3M-3	10618-108G6	14.94	7.35
chorionic membrane cells, donor1	12238-129G6	64.39	6.55
chorionic membrane cells, donor2	12239-129G7	49.82	8.95
chorionic membrane cells, donor3	12240-129G8	57.15	9.34
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	47.46	11.11
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.13	10.76
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.50	14.36
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.56	8.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	25.88	11.85
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	33.60	9.57
chronic myelogenous leukemia cell line:K562	10454-106G4	35.63	12.96
chronic myelogenous leukemia cell line:KU812	10409-106B4	28.41	12.51
clear cell carcinoma cell line:JHOC-5	10638-108I8	42.74	13.49
clear cell carcinoma cell line:TEN	10636-108I6	80.85	4.86
colon carcinoma cell line:CACO-2	10513-107D9	123.37	33.86
colon carcinoma cell line:COLO-320	10420-106C6	25.47	10.26
colon, adult, donor1	10082-102B1	41.65	2.38
colon, adult, pool1	10014-101C5	45.36	7.52
colon, fetal, donor1	10070-101I7	40.17	8.03
common myeloid progenitor CMP, donor1	12130-128D6	27.50	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	39.52	8.07
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.07	6.19
cord blood derived cell line:COBL-a untreated	10449-106F8	28.77	6.06
corpus callosum, adult, pool1	10042-101F6	59.81	7.41
cruciate ligament, donor2	10295-104G7	78.62	9.73
diaphragm, fetal, donor1	10069-101I6	80.26	4.01
diencephalon, adult	10193-103E4	49.20	4.56
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.49	8.27
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.44	8.72
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	39.72	10.83
ductus deferens, adult	10196-103E7	37.87	7.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	24.48	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	8.09
dura mater, adult, donor1	10041-101F5	49.30	10.65
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	105.04	7.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.45	11.18
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	17.88
embryonic pancreas cell line:1C3D3	10605-108F2	27.85	10.29
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.95	12.66
embryonic pancreas cell line:2C6	10603-108E9	47.28	11.82
endometrial carcinoma cell line:OMC-2	10497-107C2	71.06	21.45
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.96	11.60
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	54.19	4.82
epidermoid carcinoma cell line:A431	10426-106D3	67.14	8.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	70.39	15.51
epididymis, adult	10197-103E8	39.98	10.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	19.52	8.16
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	78.26	10.22
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	41.02	9.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.95	9.45
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.88	8.18
esophagus, adult, pool1	10015-101C6	48.84	7.33
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	52.10	18.79
eye - muscle inferior rectus, donor1	10272-104E2	149.70	19.32
eye - muscle lateral, donor2	10298-104H1	225.15	2.10
eye - muscle medial, donor2	10299-104H2	178.59	14.88
eye - muscle superior, donor2	10297-104G9	166.24	10.32
eye - vitreous humor, donor1	10268-104D7	74.33	11.66
eye, fetal, donor1	10054-101G9	51.36	8.14
fibrosarcoma cell line:HT-1080	10758-110E2	44.24	11.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	53.89	10.68
frontal lobe, adult, pool1	10040-101F4	60.89	5.82
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	46.24	19.82
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.94	22.49
gall bladder, adult	10198-103E9	31.87	7.73
gamma delta positive T cells, donor1	11937-126A2	52.61	8.05
gamma delta positive T cells, donor2	11938-126A3	47.43	8.59
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.96	3.38
gastric adenocarcinoma cell line:MKN45	10612-108F9	48.74	7.93
gastric cancer cell line:AZ521	10549-107H9	32.14	10.82
gastric cancer cell line:GSS	10560-108A2	64.98	12.81
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.71	11.19
giant cell carcinoma cell line:LU65	10487-107B1	28.46	7.00
giant cell carcinoma cell line:Lu99B	10433-106E1	25.47	7.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	56.12	10.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.20	10.66
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.56	11.80
glioblastoma cell line:T98G	10485-107A8	34.22	8.61
glioma cell line:GI-1	10413-106B8	41.30	11.42
globus pallidus - adult, donor10196	10175-103C4	36.45	3.64
globus pallidus, adult, donor10252	10161-103A8	95.69	10.98
globus pallidus, adult, donor10258	10367-105F7	94.48	4.11
globus pallidus, newborn, donor10223	10364-105F4	70.88	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	46.50	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.84	13.76
hIPS +CCl2, biol_rep1	14383-156B9	45.45	25.71
hIPS +CCl2, biol_rep2	14384-156C1	65.85	22.86
hIPS +CCl2, biol_rep3	14385-156C2	70.21	18.03
hIPS, biol_rep1	14380-156B6	80.49	7.19
hIPS, biol_rep2	14381-156B7	59.67	13.72
hIPS, biol_rep3	14382-156B8	57.38	14.35
hairy cell leukemia cell line:Mo	10712-109I1	21.55	4.02
heart - mitral valve, adult	10205-103F7	100.45	8.37
heart - pulmonic valve, adult	10206-103F8	143.29	12.55
heart - tricuspid valve, adult	10207-103F9	165.70	18.32
heart, adult, diseased post-infarction, donor1	10050-101G5	56.32	8.77
heart, adult, diseased, donor1	10051-101G6	108.16	9.79
heart, adult, pool1	10016-101C7	180.53	6.67
heart, fetal, pool1	10046-101G1	105.04	12.63
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.01	10.80
hepatoblastoma cell line:HuH-6	10633-108I3	88.00	29.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	43.31	15.47
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.36	14.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	47.90	15.87
hepatoma cell line:Li-7	10484-107A7	60.50	8.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.46	11.56
hippocampus - adult, donor10196	10169-103B7	52.99	6.62
hippocampus, adult, donor10252	10153-102I9	78.37	10.82
hippocampus, adult, donor10258	10374-105G5	86.64	0.00
hippocampus, newborn, donor10223	10363-105F3	69.79	6.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	69.58	32.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	54.59	26.12
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	62.71	36.31
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	58.64	24.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.61	27.37
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	79.34	27.71
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	18.10
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.69	15.73
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	72.99	13.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	60.62	18.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.98	14.63
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	48.48	11.45
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	42.88	30.83
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	47.16	18.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	44.51	26.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	51.16	29.40
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	55.38	20.93
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	43.48	13.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	27.51	10.74
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	28.65	11.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	33.20	10.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.15	13.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	48.19	12.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.83	17.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	54.68	28.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	55.35	30.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.29	29.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.29	22.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.19	15.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	61.43	23.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	36.20	9.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	8.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	50.54	15.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	53.17	15.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	79.51	22.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	46.71	16.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	60.14	26.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	50.81	26.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	50.73	23.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	60.82	17.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.33	24.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	12.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.62	13.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	48.40	14.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	14.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	49.97	18.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	36.37	10.78
immature langerhans cells, donor1	11904-125F5	211.64	10.41
immature langerhans cells, donor2	11905-125F6	201.20	10.30
insula, adult, pool1	10039-101F3	55.93	6.62
keratoacanthoma cell line:HKA-1	10791-110H8	37.72	10.40
kidney, adult, pool1	10017-101C8	40.25	7.91
kidney, fetal, pool1	10045-101F9	42.30	9.97
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.93	13.92
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.80	5.39
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.84	6.79
left atrium, adult, donor1	10079-102A7	74.64	11.44
left ventricle, adult, donor1	10078-102A6	136.53	13.15
leiomyoblastoma cell line:G-402	10721-110A1	31.74	19.70
leiomyoma cell line:10964C	10569-108B2	30.18	3.95
leiomyoma cell line:15242A	10570-108B3	29.35	4.89
leiomyoma cell line:15425	10571-108B4	30.35	5.58
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	90.96	18.82
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	18.30	4.60
liposarcoma cell line:KMLS-1	10782-110G8	27.96	5.78
liposarcoma cell line:SW 872	10726-110A6	35.21	9.99
liver, adult, pool1	10018-101C9	27.06	4.86
liver, fetal, pool1	10086-102B5	17.87	5.64
locus coeruleus - adult, donor10196	10182-103D2	61.39	11.08
locus coeruleus, adult, donor10252	10165-103B3	72.34	7.20
locus coeruleus, adult, donor10258	10375-105G6	42.32	5.08
locus coeruleus, newborn, donor10223	10362-105F2	57.20	5.05
lung adenocarcinoma cell line:A549	10499-107C4	31.42	8.30
lung adenocarcinoma cell line:PC-14	10408-106B3	68.25	20.68
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	74.74	23.86
lung, adult, pool1	10019-101D1	62.84	8.03
lung, fetal, donor1	10068-101I5	86.76	11.99
lung, right lower lobe, adult, donor1	10075-102A3	54.07	12.37
lymph node, adult, donor1	10077-102A5	73.84	9.94
lymphangiectasia cell line:DS-1	10727-110A7	30.90	9.42
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	55.84	10.87
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	116.38	13.59
mature adipocyte, donor1	12231-129F8	47.51	3.11
mature adipocyte, donor2	12232-129F9	58.11	5.81
mature adipocyte, donor3	12233-129G1	46.46	4.27
mature adipocyte, donor4	12234-129G2	47.12	7.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.12	12.63
medial frontal gyrus - adult, donor10196	10170-103B8	54.15	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	84.41	7.36
medial frontal gyrus, adult, donor10258	10368-105F8	50.83	6.04
medial frontal gyrus, newborn, donor10223	10352-105E1	61.84	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	56.03	10.29
medial temporal gyrus, adult, donor10252	10156-103A3	88.50	9.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	68.91	6.46
medulla oblongata - adult, donor10196	10174-103C3	40.89	5.84
medulla oblongata, adult, donor10252	10155-103A2	76.94	6.19
medulla oblongata, adult, pool1	10038-101F2	56.73	7.51
medulla oblongata, newborn, donor10223	10361-105F1	76.73	8.33
medulloblastoma cell line:D283 Med	10838-111E1	55.80	14.83
medulloblastoma cell line:ONS-76	10759-110E3	30.94	13.21
melanoma cell line:COLO 679	10514-107E1	27.17	5.89
melanoma cell line:G-361	10465-106H6	17.37	2.71
meningioma cell line:HKBMM	10691-109F7	32.20	10.67
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	13.22
merkel cell carcinoma cell line:MS-1	10844-111E7	27.48	8.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.67	6.14
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.27	5.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.58	5.38
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.75	4.64
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	32.74	5.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.28	6.25
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.60	3.95
mesenchymal precursor cell - cardiac, donor2	11753-123G7	29.90	6.33
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.93	6.23
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.87	8.91
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.59	5.98
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	26.68	6.26
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.06	7.47
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.18	4.19
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	20.21	4.70
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.63	7.19
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	24.31	6.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.95	3.19
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.15	5.87
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	25.40	4.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	29.94	7.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	39.76	7.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.77	4.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	32.42	10.10
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.16	7.76
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	39.14	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.31	9.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.98	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	41.66	6.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	47.05	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	46.76	5.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.85	8.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	33.74	5.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	39.04	6.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	39.42	5.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.25	6.04
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	41.35	6.55
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.38	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	42.22	5.52
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	32.52	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.07	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.49	7.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.61	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	36.74	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	5.86
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.34	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.32	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	36.16	6.86
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	12.84
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	52.32	9.64
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	52.94	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	28.04	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	41.98	6.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	37.88	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	31.56	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	36.24	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	40.68	5.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	39.91	6.49
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	7.13
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.82	9.28
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.67	19.37
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.36	8.11
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.20	7.60
mesothelioma cell line:Mero-25	10850-111F4	26.55	3.63
mesothelioma cell line:Mero-41	10851-111F5	44.01	5.62
mesothelioma cell line:Mero-48a	10852-111F6	92.56	9.96
mesothelioma cell line:Mero-82	10853-111F7	29.70	5.26
mesothelioma cell line:Mero-83	10854-111F8	23.49	4.09
mesothelioma cell line:Mero-84	10855-111F9	12.39	4.30
mesothelioma cell line:Mero-95	10856-111G1	33.54	4.97
mesothelioma cell line:NCI-H2052	10847-111F1	50.36	8.94
mesothelioma cell line:NCI-H226	10846-111E9	27.87	4.89
mesothelioma cell line:NCI-H2452	10848-111F2	27.16	8.20
mesothelioma cell line:NCI-H28	10845-111E8	28.50	8.14
mesothelioma cell line:No36	10857-111G2	47.95	5.87
mesothelioma cell line:ONE58	10858-111G3	83.18	5.96
migratory langerhans cells, donor1	11901-125F2	42.03	5.18
migratory langerhans cells, donor2	11902-125F3	46.04	6.47
migratory langerhans cells, donor3	11903-125F4	57.79	8.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	32.97	8.16
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	52.35	9.75
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.06	15.66
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.21	6.85
myelodysplastic syndrome cell line:SKM-1	10772-110F7	67.08	15.34
myeloma cell line:PCM6	10474-106I6	1.58	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	53.27	9.64
myxofibrosarcoma cell line:NMFH-1	10684-109E9	93.56	9.61
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.51	4.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.75	5.00
nasal epithelial cells, donor2	12227-129F4	29.26	6.07
neuroblastoma cell line:CHP-134	10508-107D4	74.08	14.26
neuroblastoma cell line:NB-1	10539-107G8	43.03	15.72
neuroblastoma cell line:NBsusSR	10607-108F4	17.29	3.59
neuroblastoma cell line:NH-12	10555-107I6	76.40	11.55
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	31.08	5.22
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.92	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	16.10	4.63
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.71	8.26
neurofibroma cell line:Hs 53.T	10729-110A9	33.54	7.72
neutrophil PMN, donor1	12133-128D9	223.12	29.75
neutrophil PMN, donor2	12137-128E4	106.25	26.56
neutrophil PMN, donor3	12141-128E8	123.12	37.88
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	93.02	29.09
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	51.23	12.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.82	8.34
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	72.00	8.41
nucleus accumbens, adult, pool1	10037-101F1	61.68	5.91
occipital cortex - adult, donor10196	10172-103C1	107.14	10.30
occipital cortex, adult, donor10252	10163-103B1	103.59	9.93
occipital cortex, newborn, donor10223	10355-105E4	107.73	5.82
occipital lobe, adult, donor1	10076-102A4	65.34	9.71
occipital lobe, fetal, donor1	10073-102A1	131.30	31.75
occipital pole, adult, pool1	10036-101E9	45.96	4.65
olfactory region, adult	10195-103E6	53.49	4.97
optic nerve, donor1	10277-104E7	84.04	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.71	10.82
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	51.52	17.86
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	54.52	10.16
oral squamous cell carcinoma cell line:SAS	10544-107H4	105.92	12.71
osteoclastoma cell line:Hs 706.T	10704-109H2	34.39	9.11
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	97.17	38.31
osteosarcoma cell line:HS-Os-1	10558-107I9	45.38	6.36
ovary, adult, pool1	10020-101D2	42.89	6.03
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.03	9.90
pancreas, adult, donor1	10049-101G4	11.29	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.36	7.55
papillary adenocarcinoma cell line:8505C	10437-106E5	34.24	5.79
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	135.78	19.70
paracentral gyrus, adult, pool1	10035-101E8	63.97	5.86
parietal cortex, adult, donor10258	10373-105G4	65.33	0.00
parietal lobe - adult, donor10196	10171-103B9	50.79	5.64
parietal lobe, adult, donor10252	10157-103A4	70.97	9.12
parietal lobe, adult, pool1	10034-101E7	58.34	6.17
parietal lobe, fetal, donor1	10072-101I9	119.29	28.13
parietal lobe, newborn, donor10223	10356-105E5	80.38	7.48
parotid gland, adult	10199-103F1	37.62	9.25
penis, adult	10200-103F2	88.62	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.18	3.16
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.17	9.91
pineal gland - adult, donor10196	10179-103C8	76.76	12.26
pineal gland, adult, donor10252	10160-103A7	88.83	8.88
pineal gland, adult, donor10258	10377-105G8	58.32	10.03
pituitary gland - adult, donor10196	10180-103C9	64.76	10.12
pituitary gland, adult, donor10252	10162-103A9	108.93	14.59
pituitary gland, adult, donor10258	10378-105G9	58.74	8.51
placenta, adult, pool1	10021-101D3	46.76	5.91
plasma cell leukemia cell line:ARH-77	10840-111E3	55.35	13.90
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.60	4.05
pons, adult, pool1	10033-101E6	56.29	8.78
postcentral gyrus, adult, pool1	10032-101E5	47.77	5.14
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74
prostate cancer cell line:DU145	10490-107B4	35.10	15.15
prostate cancer cell line:PC-3	10439-106E7	74.42	22.51
prostate, adult, pool1	10022-101D4	49.15	7.16
putamen, adult, donor10196	10176-103C5	63.03	6.14
putamen, adult, donor10252	10152-102I8	90.19	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	90.70	10.93
putamen, adult, donor10258, tech_rep2	10372-105G3	71.03	4.35
putamen, newborn, donor10223	10365-105F5	37.48	1.50
rectal cancer cell line:TT1TKB	10469-106I1	69.53	10.47
rectum, fetal, donor1	10067-101I4	40.34	26.43
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.23	7.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	38.52	5.80
retina, adult, pool1	10030-101E3	36.38	5.96
retinoblastoma cell line:Y79	10475-106I7	34.81	16.11
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.67	10.45
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	37.40	17.43
sacrococcigeal teratoma cell line:HTST	10695-109G2	62.90	23.49
salivary acinar cells, donor1	11771-123I7	30.27	8.90
salivary acinar cells, donor2	11772-123I8	21.89	9.09
salivary acinar cells, donor3	11773-123I9	51.64	11.92
salivary gland, adult, pool1	10093-102C3	29.74	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.64	14.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.03	13.17
seminal vesicle, adult	10201-103F3	39.68	6.88
serous adenocarcinoma cell line:JHOS-2	10639-108I9	81.62	10.45
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	77.25	9.56
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	57.20	9.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	98.73	8.87
signet ring carcinoma cell line:Kato III	10436-106E4	32.27	3.54
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.74	6.97
skeletal muscle - soleus muscle, donor1	10282-104F3	459.65	34.05
skeletal muscle, adult, pool1	10023-101D5	403.71	14.87
skeletal muscle, fetal, donor1	10066-101I3	14.07	2.01
skin, adult, donor1	10074-102A2	13.57	6.79
skin, fetal, donor1	10065-101I2	44.19	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.69	6.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	75.02	13.87
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.75	34.50
small cell lung carcinoma cell line:LK-2	10541-107H1	23.90	5.44
small cell lung carcinoma cell line:NCI-H82	10842-111E5	67.56	10.94
small cell lung carcinoma cell line:WA-hT	10562-108A4	61.45	6.97
small intestine, adult, pool1	10024-101D6	46.94	7.64
small intestine, fetal, donor1	10064-101I1	26.54	9.58
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	30.26	5.13
smooth muscle, adult, pool1	10048-101G3	43.42	8.79
somatostatinoma cell line:QGP-1	10781-110G7	20.64	10.99
spinal cord - adult, donor10196	10181-103D1	49.32	13.53
spinal cord, adult, donor10252	10159-103A6	67.42	5.52
spinal cord, adult, donor10258	10369-105F9	69.18	1.38
spinal cord, fetal, donor1	10056-101H2	47.57	6.71
spinal cord, newborn, donor10223	10359-105E8	67.50	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.38	8.21
spleen, adult, pool1	10025-101D7	74.34	9.80
spleen, fetal, pool1	10044-101F8	49.50	9.14
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.16	9.63
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.73	7.78
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	60.11	7.69
squamous cell carcinoma cell line:T3M-5	10616-108G4	96.95	17.98
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	80.70	13.17
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	46.17	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	64.31	12.27
stomach, fetal, donor1	10062-101H8	30.97	22.43
submaxillary gland, adult	10202-103F4	45.57	6.84
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	76.02	7.27
substantia nigra, adult, donor10258	10371-105G2	79.66	1.55
substantia nigra, newborn, donor10223	10358-105E7	55.11	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	167.82	16.51
temporal lobe, adult, pool1	10031-101E4	38.82	5.09
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	112.54	32.05
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	149.44	14.94
tenocyte, donor1	11763-123H8	87.97	5.93
tenocyte, donor2	11765-123I1	86.60	3.82
tenocyte, donor3	11768-123I4	66.35	5.93
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	87.53	44.53
teratocarcinoma cell line:NCR-G1	10798-110I6	29.90	11.41
teratocarcinoma cell line:PA-1	10807-111A6	36.57	29.14
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	42.15	24.37
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.96	15.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.63	7.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.80	39.41
testis, adult, pool1	10026-101D8	38.98	6.01
testis, adult, pool2	10096-102C6	41.05	5.86
thalamus - adult, donor10196	10168-103B6	58.51	6.62
thalamus, adult, donor10252	10154-103A1	85.17	5.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	178.60	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	53.03	7.25
thalamus, newborn, donor10223	10366-105F6	40.27	9.78
throat, adult	10209-103G2	172.27	7.24
throat, fetal, donor1	10061-101H7	31.99	9.75
thymic carcinoma cell line:Ty-82	10803-111A2	34.18	4.77
thymus, adult, pool1	10027-101D9	43.34	8.15
thymus, fetal, pool1	10043-101F7	59.85	7.59
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.48	13.16
thyroid carcinoma cell line:TCO-1	10783-110G9	41.63	7.26
thyroid, adult, pool1	10028-101E1	47.78	10.45
thyroid, fetal, donor1	10060-101H6	34.80	16.08
tongue epidermis (fungiform papillae), donor1	10288-104F9	144.74	18.48
tongue, adult	10203-103F5	161.64	5.58
tongue, fetal, donor1	10059-101H5	78.42	8.28
tonsil, adult, pool1	10047-101G2	55.10	8.21
trachea, adult, pool1	10029-101E2	50.22	7.53
trachea, fetal, donor1	10058-101H4	48.47	5.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.59	10.98
transitional-cell carcinoma cell line:5637	10418-106C4	77.51	11.04
transitional-cell carcinoma cell line:JMSU1	10492-107B6	35.41	23.19
tridermal teratoma cell line:HGRT	10694-109G1	76.10	26.64
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	60.78	10.41
umbilical cord, fetal, donor1	10057-101H3	35.47	12.52
uterus, adult, pool1	10100-102D1	63.47	9.04
uterus, fetal, donor1	10055-101H1	37.37	8.19
vagina, adult	10204-103F6	60.74	9.69
vein, adult	10191-103E2	52.17	8.33
xeroderma pigentosum b cell line:XPL 17	10563-108A5	32.04	5.07